(Q45208623)

10 December 2017

0 references

Intradermal vs intramuscular vaccine against hepatitis B infection in dialysis patients: a meta-analysis of randomized trials (English)

1 reference

10 December 2017

0 references

1 reference

3

P Messa

1 reference

10 December 2017

F. Fabrizi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20819147

7 July 2024

V. Dixit

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20819147

7 July 2024

P. Martin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20819147

7 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20819147

7 July 2024

publication date

31 August 2010

1 reference

full work available at URL

10 December 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2893.2010.01354.x

1 reference

https://api.crossref.org/works/10.1111/J.1365-2893.2010.01354.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2893.2010.01354.x/fullpdf

7 July 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2893.2010.01354.X

Journal of Viral Hepatitis

7 July 2024

published in

1 reference

10 December 2017

volume

18

1 reference

10 December 2017

issue

10

1 reference

10 December 2017

page(s)

730-737

1 reference

Intradermal hepatitis B vaccination: a systematic review and meta-analysis

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01354.X

Meta-analysis: intradermal vs. intramuscular vaccination against hepatitis B virus in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01354.X

The retrieval of randomized clinical trials in liver disease from the medical literature. A comparison of MEDLARS and manual methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01354.X

Approaches to heterogeneity in meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01354.X

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01354.X

A note on graphical presentation of estimated odds ratios from several clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01354.X

Total parenteral nutrition and cancer clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01354.X

A randomized comparison of intradermal and intramuscular vaccination against hepatitis B virus in incident chronic hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01354.X

Efficacy and side effects of intradermal hepatitis B vaccination in CAPD patients: a comparison with the intramuscular vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01354.X

Low Dose Intradermal Versus High Dose Intramuscular Hepatitis B Vaccination in Patients on Chronic Hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01354.X

Cellular metabolism as a basis for immune privilege

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01354.X

Levamizole enhances immune responsiveness to intra-dermal and intra-muscular hepatitis B vaccination in chronic hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01354.X

Intradermal versus intramuscular hepatitis B vaccination in hemodialysis patients: a prospective open-label randomized controlled trial in nonresponders to primary vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01354.X

Immunogenicity and safety of an adjuvanted hepatitis B vaccine in pre-hemodialysis and hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01354.X

Recombinant interferon-alpha2b improves immune response to hepatitis B vaccination in haemodialysis patients: results of a randomised clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01354.X

Granulocyte-macrophage colony-stimulating factor enhances the efficacy of hepatitis B virus vaccine in previously unvaccinated haemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01354.X

Effects of oral levamisole as an adjuvant to hepatitis B vaccine in adults with end-stage renal disease: a meta-analysis of controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01354.X

Stage of chronic kidney disease predicts seroconversion after hepatitis B immunization: earlier is better

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01354.X

Are booster immunisations needed for lifelong hepatitis B immunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01354.X

Optimization of a jet-propelled particle injection system for the uniform transdermal delivery of drug/vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01354.X

Randomized trials published in some Chinese journals: how many are randomized?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01354.X

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01354.X

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01354.X

Vaccine recommendations for patients on chronic dialysis. The Advisory Committee on Immunization Practices and the American Academy of Pediatrics

21 January 2018

2

1 reference

https://api.crossref.org/works/10.1111/J.1365-2893.2010.01354.X

Meta-analysis in clinical trials

7 July 2024

6

1 reference

https://api.crossref.org/works/10.1111/J.1365-2893.2010.01354.X

Intracutaneous versus intramuscular hepatitis B vaccination in primary non-responding haemodialysis patients

7 July 2024

12

1 reference

https://api.crossref.org/works/10.1111/J.1365-2893.2010.01354.X

Low-dose intradermal versus intramuscular hepatitis B vaccination in patients with end-stage renal failure. A preliminary study

7 July 2024

13

1 reference

https://api.crossref.org/works/10.1111/J.1365-2893.2010.01354.X

Intradermal versus intramuscular hepatitis b re-vaccination in non-responsive chronic dialysis patients: a prospective randomized study with cost-effectiveness evaluation

7 July 2024

14

1 reference

https://api.crossref.org/works/10.1111/J.1365-2893.2010.01354.X

Reinforced intradermal hepatitis B vaccination in hemodialysis patients is superior in antibody response to intramuscular or subcutaneous vaccination

7 July 2024

15

1 reference

https://api.crossref.org/works/10.1111/J.1365-2893.2010.01354.X

An intradermal vaccine protocol against hepatitis B in a haemodialysis population

7 July 2024

16

1 reference

https://api.crossref.org/works/10.1111/J.1365-2893.2010.01354.X

Comparison of intramuscular and intradermal applications of hepatitis B vaccine in hemodialysis patients

7 July 2024

21

1 reference

https://api.crossref.org/works/10.1111/J.1365-2893.2010.01354.X

Low dose intradermal vaccination is superior to high dose intramuscular vaccination for hepatitis B in unresponsive hemodialysis patients

7 July 2024

23

1 reference

https://api.crossref.org/works/10.1111/J.1365-2893.2010.01354.X

Recombinant hepatitis B vaccine use in chronic hemodialysis patients. Long-term evaluation and cost-effectiveness analysis

7 July 2024

25

1 reference

https://api.crossref.org/works/10.1111/J.1365-2893.2010.01354.X

Rapid, enhanced, and persistent protection of patients with renal insufficiency by AS02(V)-adjuvanted hepatitis B vaccine

7 July 2024

27

1 reference

https://api.crossref.org/works/10.1111/J.1365-2893.2010.01354.X

Controlled trial of thymopentin in hemodialysis patients who fail to respond to hepatitis B vaccination

7 July 2024

29

1 reference

https://api.crossref.org/works/10.1111/J.1365-2893.2010.01354.X

Complete Seroconversion by Low-Dose Intradermal Injection of Recombinant Hepatitis B Vaccine in Hemodialysis Patients

7 July 2024

33

1 reference

https://api.crossref.org/works/10.1111/J.1365-2893.2010.01354.X

A successful two-step integrated protocol of anti-HBV vaccination in chronic uremia

7 July 2024

34

1 reference

https://api.crossref.org/works/10.1111/J.1365-2893.2010.01354.X

Needle-free injection of DNA vaccines: a brief overview and methodology

7 July 2024

37

1 reference

https://api.crossref.org/works/10.1111/J.1365-2893.2010.01354.X

7 July 2024

Identifiers

1 reference

10 December 2017

1 reference